Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the potential effect of antiretroviral treatment during pregnancy using data from a national surveillance study. Method: Fasting lipid measurements collected during routine care in pregnancy were used, analyzing longitudinal changes and differences in lipid values at each trimester by protease inhibitors (Pls) and stavudine use. Multivariate analyses were used to control for simultaneous factors potentially leading to hyperlipidemia. Study population included 248 women. Results: Lipid values increased progressively and significantly during pregnancy: mean increases between the first and third trimesters were 141.6 mg/dL for triglycerides (p <.001), 60.8 mg/dL for total cholesterol (p <.001), 13.7 mg/dL for HDL cholesterol (p <.001), and 17.8 mg/dL for LDL cholesterol (p =.001). At all trimesters, women on PIs had significantly higher triglyceride values compared to women not on Pis. The effect of Pls on cholesterol levels was less consistent. Stavudine showed a dyslipidemic effect at first trimester only. Multivariate analyses confirmed these observations and suggested a potential role of other cofactors in the development of hyperlipidemia during pregnancy. Conclusion: The changes observed point to the need to further explore the causes and the clinical correlates of hyperlipidemia during pregnancy in women with HIV.

Lipid profile during pregnancy in HIV-infected women / M., Floridia; E., Tamburrini; M., Ravizza; C., Tibaldi; M. F., Ravizza Probizer; G., Anzidei; M., Sansone; F., Mori; E., Rubino; M., Meli; S., Dalzero; Guaraldi, Giovanni; Italian Group on Surveillance on Antiretroviral Treatment in, Pregnancy. - In: HIV CLINICAL TRIALS. - ISSN 1528-4336. - STAMPA. - 2006 Jul-Aug;7(4):(2006), pp. 184-193. [10.1310/hct0704-184]

Lipid profile during pregnancy in HIV-infected women

GUARALDI, Giovanni;
2006-01-01

Abstract

Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the potential effect of antiretroviral treatment during pregnancy using data from a national surveillance study. Method: Fasting lipid measurements collected during routine care in pregnancy were used, analyzing longitudinal changes and differences in lipid values at each trimester by protease inhibitors (Pls) and stavudine use. Multivariate analyses were used to control for simultaneous factors potentially leading to hyperlipidemia. Study population included 248 women. Results: Lipid values increased progressively and significantly during pregnancy: mean increases between the first and third trimesters were 141.6 mg/dL for triglycerides (p <.001), 60.8 mg/dL for total cholesterol (p <.001), 13.7 mg/dL for HDL cholesterol (p <.001), and 17.8 mg/dL for LDL cholesterol (p =.001). At all trimesters, women on PIs had significantly higher triglyceride values compared to women not on Pis. The effect of Pls on cholesterol levels was less consistent. Stavudine showed a dyslipidemic effect at first trimester only. Multivariate analyses confirmed these observations and suggested a potential role of other cofactors in the development of hyperlipidemia during pregnancy. Conclusion: The changes observed point to the need to further explore the causes and the clinical correlates of hyperlipidemia during pregnancy in women with HIV.
2006 Jul-Aug;7(4)
184
193
Lipid profile during pregnancy in HIV-infected women / M., Floridia; E., Tamburrini; M., Ravizza; C., Tibaldi; M. F., Ravizza Probizer; G., Anzidei; M., Sansone; F., Mori; E., Rubino; M., Meli; S., Dalzero; Guaraldi, Giovanni; Italian Group on Surveillance on Antiretroviral Treatment in, Pregnancy. - In: HIV CLINICAL TRIALS. - ISSN 1528-4336. - STAMPA. - 2006 Jul-Aug;7(4):(2006), pp. 184-193. [10.1310/hct0704-184]
M., Floridia; E., Tamburrini; M., Ravizza; C., Tibaldi; M. F., Ravizza Probizer; G., Anzidei; M., Sansone; F., Mori; E., Rubino; M., Meli; S., Dalzero; Guaraldi, Giovanni; Italian Group on Surveillance on Antiretroviral Treatment in, Pregnancy
File in questo prodotto:
File Dimensione Formato  
Lipid Profile During Pregnancy.pdf

Open access

Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 214.82 kB
Formato Adobe PDF
214.82 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/305151
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact